Passage Bio, Inc.
PASG · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $34,250 | $55,290 | $75,112 | $338,734 |
| - Cash | $37,573 | $21,709 | $34,601 | $128,965 |
| + Debt | $25,476 | $26,294 | $27,107 | $0 |
| Enterprise Value | $22,153 | $59,875 | $67,618 | $209,769 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$3,721 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$62,086 | -$98,341 | -$131,715 | -$176,186 |
| % Margin | – | – | – | – |
| Net Income | -$64,767 | -$102,062 | -$136,125 | -$185,386 |
| % Margin | – | – | – | – |
| EPS Diluted | -21.44 | -37.29 | -50 | -69.51 |
| % Growth | 42.5% | 25.4% | 28.1% | – |
| Operating Cash Flow | -$47,956 | -$78,264 | -$118,210 | -$126,879 |
| Capital Expenditures | -$34 | -$146 | -$5,274 | -$25,642 |
| Free Cash Flow | -$47,990 | -$78,410 | -$123,484 | -$152,521 |